United States · 
Who invested in Atalanta Therapeutics?
Atalanta Therapeutics's investors include Sanofi and EQT Life Sciences.
United States · Series B startup
Who invested in Atalanta Therapeutics
Funding summaryUpdated 26 Oct 2026
$97Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $97MJan 2025
- Investors
- 2
The rounds
- Jan 2025
Founders and team
From Atalanta Therapeutics's own website: 1 on the team.
- Evan TzanisChief Development Officer
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Atalanta Therapeutics
How much has Atalanta Therapeutics raised?
Atalanta Therapeutics has raised $97M across 1 round since 2025.
When did Atalanta Therapeutics last raise?
Atalanta Therapeutics's most recent round was a Series B of $97M in Jan 2025.
What was Atalanta Therapeutics's biggest round?
Its most recent round, $97M in Jan 2025, is also its largest on record.
Who backed Atalanta Therapeutics first?
Atalanta Therapeutics's first round on record, in Jan 2025, was backed by Sanofi and EQT Life Sciences.
What stage is Atalanta Therapeutics at?
Atalanta Therapeutics's latest named round is a Series B, in Jan 2025.
Where is Atalanta Therapeutics based?
Atalanta Therapeutics is based in the United States.
Companies like Atalanta Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.